LONDON – U.K. newco Centauri Therapeutics Ltd. has acquired the alphamer anti-infective technology inspired by Nobel Laureate and inventor of the polymerase chain reaction Kary Mullis, and raised £3 million (US$4.3 million) to complete preclinical development of the lead compound.